A report released today by Zacks Investment Research about Herbalife Ltd. (NYSE:HLF) bumps the target price to $68.00
- Updated: September 22, 2016
Herbalife Ltd. (NYSE:HLF) had its target bumped up to $68.00 by Zacks Investment Research in an issued report announced Thursday September 22, 2016. The bumped up target suggests a potential upside of 0.12% based on the company's previous closing price.
Yesterday Herbalife Ltd. (NYSE:HLF) traded 0.79% higher at $60.93. The company’s 50-day moving average is $63.17 and its 200-day moving average is $61.23. The last stock close price is down -0.49% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Trading volume was down over the average, with 716,608 shares of HLF changing hands under the typical 2,249,740
Recent Performance Chart
With a total market value of $0, Herbalife Ltd. has one year low of $42.26 and a one year high of $72.22 with a price-earnings ratio of 20.88 .
Brief Synopsis About Herbalife Ltd. (NYSE:HLF)
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. The Company's segments include North America; Mexico; South & Central America; Europe, Middle East, and Africa (EMEA); Asia Pacific, and China. The Company markets and sells over 140 products, encompassing approximately 5,000 stock keeping units (SKUs) globally. Its product categories include Weight Management; Targeted Nutrition; Energy, Sports and Fitness; Outer Nutrition, and Literature, Promotional and Other. The Company's representative products include Formula 1 Healthy Meal, Herbal Tea Concentrate, Protein Drink Mix, Personalized Protein Powder, Total Control, Prolessa Duo, Protein Bars, Aloe Concentrate, Niteworks, Garden 7 phytonutrient supplement, Best Defense for improved immune system, COQ10 Plus and Herbalife SKIN line.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.